Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Atorvastatin on Bone Markers in Post-Menopausal Women
NCT02342015Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Nov 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in hypercholesterolemia, sponsored by Università di Padova. Primary endpoints: Relative Change in OPG/RANK/RANKL mRNA Expression in Isolated T Cells and Monocytes at 3 months and Change in Circulating Levels of Osteoprogenitor Cells (CD34+/OCN+/BAP+ Cells) at 3 months. Started Nov 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02342015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342015.